| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/02/2009 | WO2009042177A1 6-, 7-, or 8-substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 04/02/2009 | WO2009042139A1 2-s-benzyl substituted pyrimidines as crth2 antagonists |
| 04/02/2009 | WO2009042138A1 Alkylthio pyrimidines as crth2 antagonists |
| 04/02/2009 | WO2009042114A2 Phenazine derivatives and uses thereof |
| 04/02/2009 | WO2009042098A1 Chromenone derivatives and their use for leukotriene biosynthesis inhibition |
| 04/02/2009 | WO2009042094A2 Hiv protease inhibitors |
| 04/02/2009 | WO2009042081A1 Valomaciclovir polymorphs |
| 04/02/2009 | WO2009041905A1 Pteridine compounds having activity on the gaba- receptors |
| 04/02/2009 | WO2009041904A1 Quinoline compounds having an activity against the gabab receptor |
| 04/02/2009 | WO2009041799A1 Pharmaceutical composition combining diacerein and chondroitin sulphate and use thereof in the treatment of osteoarthritis and related diseases |
| 04/02/2009 | WO2009041798A1 Pharmaceutical compositions combining a nonsteroidal anti-inflammatory agent and a xanthine oxidase inhibiting agent, which can be used to control and treat gout, gouty arthritis and related diseases |
| 04/02/2009 | WO2009041790A1 Novel 2,4,5-trisubtituted-1,3-thiazole derivatives and pharmaceutically acceptable salt thereof, method for preparation, therapeutic agent for inflammatory disease induced by spc activity containing 2,4,5- trisubstituted-1,3-thiazole derivatives as an effective ingredient |
| 04/02/2009 | WO2009041765A1 Pharmaceutical composition containing esomeprazole |
| 04/02/2009 | WO2009041714A1 External preparation for free radical diseases |
| 04/02/2009 | WO2009041700A1 Pharmaceutical composition |
| 04/02/2009 | WO2009041666A1 Cyclodextrin compound modified with folic acid, process for production thereof, drug delivery agent for targeting drug delivery system, pharmaceutical composition, and imaging agent |
| 04/02/2009 | WO2009041663A1 Agent for prevention and/or treatment of skin diseases |
| 04/02/2009 | WO2009041640A1 Plant extract and use thereof |
| 04/02/2009 | WO2009041591A1 Fused pyridine derivative |
| 04/02/2009 | WO2009041570A1 Polymer conjugate of steroid |
| 04/02/2009 | WO2009041567A1 Diaryl ketimine derivative having antagonistic activity on melanin-concentrating hormone receptor |
| 04/02/2009 | WO2009041566A1 Preventive or remedy for posterior eye diseases containing quinazolinone derivative or quinoxaline derivative as the active ingredient |
| 04/02/2009 | WO2009041565A1 Quinazolinone derivative, and prophylactic or therapeutic agent for corneal/conjunctival disorder comprising quinazolinone derivative as active ingredient |
| 04/02/2009 | WO2009041559A1 Indazole acrylic acid amide compound |
| 04/02/2009 | WO2009041549A1 Ophthalmic composition |
| 04/02/2009 | WO2009041521A1 Quinolone derivative |
| 04/02/2009 | WO2009041456A1 Imidazopyridazine derivative |
| 04/02/2009 | WO2009041453A1 Bicyclic γ-amino acid derivative |
| 04/02/2009 | WO2009041449A1 Antiobesity agent |
| 04/02/2009 | WO2009041447A1 5-membered heterocyclic compound |
| 04/02/2009 | WO2009041072A1 Prophylactic and/or therapeutic agent for anemia, comprising tetrahydroquinoline compound as active ingredient |
| 04/02/2009 | WO2009041037A1 Drug for suppressing pathogen occurring in vivo |
| 04/02/2009 | WO2009040952A1 Drug containing benzophenone derivative or its salt |
| 04/02/2009 | WO2009040849A1 Use of amino acid l-kynurenine and derivatives thereof for the treatment of chronic inflammatory pathologies |
| 04/02/2009 | WO2009040819A2 DOWN-REGULATION OF MORTALIN BY siRNA |
| 04/02/2009 | WO2009040817A2 Salarins and tulearins, compositions and uses thereof |
| 04/02/2009 | WO2009040816A1 Methods of treating lysosomal storage disorders |
| 04/02/2009 | WO2009040776A1 Self-emulsifying pharmaceutical compositions of rhein or diacerein |
| 04/02/2009 | WO2009040755A2 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof ans intermediates thereto |
| 04/02/2009 | WO2009040754A2 Polymorphs of s-(-)-9-fluoro-6,7-dihydro-8-(4-hydroxypiperidin-1-yl)-5-methyl-1-oxo-1h,5h-benzo[i,j]quinolizine-2-carboxylic acid lysine salt |
| 04/02/2009 | WO2009040702A2 Pharmaceutical compositions of rhein or diacerein |
| 04/02/2009 | WO2009040671A1 Novel therapeutic uses of adrenergic alpha-1 receptor antagonists |
| 04/02/2009 | WO2009040595A1 Multi-dose pharmaceutical composition of analgesic for nasal administration |
| 04/02/2009 | WO2009040556A1 Pyrimidine derivatives as protein kinase inhibitors |
| 04/02/2009 | WO2009040552A2 Substituted imidazo (2, 1-b) -1, 3, 4-thiazole compounds, their pharmaceutical compositions and uses thereof |
| 04/02/2009 | WO2009040512A2 Modulation of rsk |
| 04/02/2009 | WO2009040507A1 Substituted benamidines as antibacterial agents |
| 04/02/2009 | WO2009040456A1 Novel chemotherapeutic agents for treating cancer |
| 04/02/2009 | WO2009040445A2 Arabinoxylo-oligosaccharides useful against gastrointestinal infections |
| 04/02/2009 | WO2009040427A1 Galenical formulations of organic compounds |
| 04/02/2009 | WO2009040426A1 Immunoliposomes for treatment of cancer |
| 04/02/2009 | WO2009040423A1 Use of tocopherol derivatives as inhibitors of the notch signalling pathway |
| 04/02/2009 | WO2009040420A2 Use of a monoterpene to increase tissue repair |
| 04/02/2009 | WO2009040411A1 Photodynamic therapy and diagnosis using a chlorin e4 zinc complex |
| 04/02/2009 | WO2009040410A1 Oxadiazole- and oxazole-substituted benzimidazole- and indole-derivatives as dgat1 inhibitors |
| 04/02/2009 | WO2009040405A1 Compound and use thereof in the treatment of amyloidosis |
| 04/02/2009 | WO2009040399A1 Substituted pyrrolo-pyrimidine derivatives, process for their preparation and their use as kinase inhibitors |
| 04/02/2009 | WO2009040394A1 Use of a combination of an opioid agonist and an opioid antagonist for the treatment of crohn´s disease and the symptoms associated with crohn´s disease |
| 04/02/2009 | WO2009040388A1 Controlled release tamsulosin hydrochloride tablets and a process of making them |
| 04/02/2009 | WO2009040314A2 Novel heteroaryl-substituted acetone derivatives, suitable for inhibiting phospholipase a2 |
| 04/02/2009 | WO2009040290A1 Quinoline derivatives as 5ht5a receptor antagonists |
| 04/02/2009 | WO2009040288A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives |
| 04/02/2009 | WO2009040269A1 Nucleoside derivatives as inhibitors of viral polymerases |
| 04/02/2009 | WO2009040092A2 Pna conjugates targeted to the emu enhancer of the igh locus as therapeutic agent for bcl-2 translocation driven follicular cell lymphoma clonal expansion |
| 04/02/2009 | WO2009040075A1 Blockers of serotonin and its receptors for the treatment of hepatitis |
| 04/02/2009 | WO2009039944A1 Phenothiazine derivative having a double bond, method for the production thereof, and use thereof as a pharmaceutical |
| 04/02/2009 | WO2009039943A1 (carboxylalkylene-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament |
| 04/02/2009 | WO2009039942A1 (cyclopropyl-phenyl)-phenyl-oxalamides, method for the production thereof, and use of same as a medicament |
| 04/02/2009 | WO2009039859A1 Ring-substituted phenyl pyrrole aminoguanidine derivatives |
| 04/02/2009 | WO2009039773A1 New medicine use of 1-substituted aryl -2(1h)-pyridone |
| 04/02/2009 | WO2009039731A1 Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof |
| 04/02/2009 | WO2009039657A1 High concentration chitosan-nucleic acid polyplex compositions |
| 04/02/2009 | WO2009039644A1 Adipose resolve apparatus for low-power laser |
| 04/02/2009 | WO2009039635A1 Methods of modulating neurotrophin-mediated activity |
| 04/02/2009 | WO2009039628A1 Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo |
| 04/02/2009 | WO2009039567A1 Molecular delivery vesicle |
| 04/02/2009 | WO2009039553A1 Benzothiazole compounds |
| 04/02/2009 | WO2009023299A9 Anti-angiogenic agents and methods of use |
| 04/02/2009 | WO2009023269A3 4-(9-(3, 3-difluorocyclopentyl) -5, 7, 7-trimethyl-6-oxo-6, 7, 8, 9-tetrahydro-5h-pyrimido [4, 5-b[1, 4] diazepin-2-ylamino)-3-methoxybenzamide derivatives as inhibitors of the human protein kinases plk1 to plk4 for the treatment of proliferative diseases |
| 04/02/2009 | WO2009021747A3 Treatment of duchenne muscular dystrophy |
| 04/02/2009 | WO2009021656A3 Tablet containing donepezile hydrochloride in amorphous form |
| 04/02/2009 | WO2009020317A3 Stabilized antioxidant particles, composition comprising the same and method for preparing the same |
| 04/02/2009 | WO2009020314A3 Stabilized alpha-lipoic acid particles, composition comprising the same and method for preparing the same |
| 04/02/2009 | WO2009019721A3 Quercetin derivatives as anti-cancer agents |
| 04/02/2009 | WO2009019668A3 Packaging kit for statins and compositions thereof |
| 04/02/2009 | WO2009019553A3 Imidazopyridinones |
| 04/02/2009 | WO2009019303A3 A process for the preparation or purification of olmesartan medoxomil |
| 04/02/2009 | WO2009016227A3 Novel compounds |
| 04/02/2009 | WO2009015996A3 Reduction of oxidative stress damage during or after exercise |
| 04/02/2009 | WO2009015112A3 Metal complexes incorporated within biodegradable nanoparticles and their use |
| 04/02/2009 | WO2009014910A3 N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 receptor for the treatment of diabetes and metabolic disorders |
| 04/02/2009 | WO2009014417A3 An antiviral composition |
| 04/02/2009 | WO2009013356A3 Anti-hiv tablet formulations comprising darunavir |
| 04/02/2009 | WO2009012960A3 Abrasion-resistant free-flowing glycocyamine-containing mouldings and methods for their production |
| 04/02/2009 | WO2009012733A3 Method of manufacture of compressed pharmaceutical formulation containing tibolone |
| 04/02/2009 | WO2009012425A3 Compositions including leukotriene antagonists and nsaids and methods of using the same |
| 04/02/2009 | WO2009011880A3 Heterocyclic modulators of pkb |
| 04/02/2009 | WO2009010787A3 Stable pharmaceutical compositions comprising one or more hmg-coa reductase inhibitors |
| 04/02/2009 | WO2009010492A3 Combinations comprising telmisartan and an anticholinergic such as tiotropium or a glycopyrronium salt for the treatment of respiratory diseases such as copd or asthma |
| 04/02/2009 | WO2009010299A8 Substituted heteroarylpiperidine derivatives as melanocortin-4 receptor modulators |